Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 23Recruiting 8Unknown 4Terminated 4Withdrawn 2Active not recruiting 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 2Polycystic Ovary Syndrome 1Insulin Resistance 1Breast Neoplasms 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × High-Intensity Interval Training × Clear all
NCT06190600 2025-04-30

SPORTNATHy

The Greater Poland Cancer Centre

Phase NA Active not recruiting
40 enrolled
Breast

Breast Neoplasms, Motor Activity

NCT02303470 2024-06-20

PCOS & Insulin Resistance Exercise Study

University of California, San Francisco

Phase NA Active not recruiting
47 enrolled

Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡